全文获取类型
收费全文 | 8197篇 |
免费 | 536篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 211篇 |
妇产科学 | 84篇 |
基础医学 | 962篇 |
口腔科学 | 323篇 |
临床医学 | 1081篇 |
内科学 | 1354篇 |
皮肤病学 | 49篇 |
神经病学 | 730篇 |
特种医学 | 306篇 |
外科学 | 903篇 |
综合类 | 526篇 |
一般理论 | 12篇 |
预防医学 | 972篇 |
眼科学 | 159篇 |
药学 | 670篇 |
中国医学 | 3篇 |
肿瘤学 | 369篇 |
出版年
2023年 | 41篇 |
2022年 | 27篇 |
2021年 | 140篇 |
2020年 | 97篇 |
2019年 | 142篇 |
2018年 | 208篇 |
2017年 | 131篇 |
2016年 | 164篇 |
2015年 | 166篇 |
2014年 | 231篇 |
2013年 | 352篇 |
2012年 | 604篇 |
2011年 | 689篇 |
2010年 | 354篇 |
2009年 | 319篇 |
2008年 | 582篇 |
2007年 | 672篇 |
2006年 | 587篇 |
2005年 | 599篇 |
2004年 | 587篇 |
2003年 | 586篇 |
2002年 | 496篇 |
2001年 | 103篇 |
2000年 | 96篇 |
1999年 | 76篇 |
1998年 | 94篇 |
1997年 | 52篇 |
1996年 | 44篇 |
1995年 | 49篇 |
1994年 | 48篇 |
1993年 | 45篇 |
1992年 | 34篇 |
1991年 | 28篇 |
1990年 | 25篇 |
1989年 | 38篇 |
1988年 | 24篇 |
1987年 | 28篇 |
1986年 | 29篇 |
1985年 | 23篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 12篇 |
1980年 | 11篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1974年 | 8篇 |
1973年 | 7篇 |
1972年 | 6篇 |
排序方式: 共有8749条查询结果,搜索用时 15 毫秒
1.
2.
Conall T. Morgan Brigitte Mueller Varsha Thakur Vitor Guerra Callaghan Jull Luc Mertens Mark Friedberg Fraser Golding Mike Seed Steven E.S. Miner Edgar T. Jaeggi Cedric Manlhiot Lynne E. Nield 《The Canadian journal of cardiology》2019,35(4):453-461
Background
The purpose of the study was to evaluate the association between fetal echocardiographic measurements and the need for intervention (primary coarctation repair, staged coarctation repair, or catheter intervention) in prenatally diagnosed coarctation of the aorta.Methods
A single-centre retrospective cohort study (2005-2015) of 107 fetuses diagnosed with suspected coarctation of the aorta in the setting of an apex-forming left ventricle and antegrade flow across the mitral and aortic valves.Results
Median gestational age at diagnosis was 32 weeks (interquartile range, 23-35 weeks). Fifty-six (52%) did not require any neonatal intervention, 51 patients (48%) underwent a biventricular repair. In univariable analysis, an increase in ascending aorta (AAo) peak Doppler flow velocity (odds ratio [OR], 1.40 [95% confidence interval [CI], 1.05-1.91] per 20 cm/s; P = 0.03) was associated with intervention. No intervention was associated with larger isthmus size (OR, 0.23; P < 0.001), transverse arch diameter (OR, 0.23; P < 0.001), and aortic (OR, 0.72; P = 0.02), mitral (OR, 0.58; P = 0.001), and AAo (OR, 0.53; P < 0.001) z-scores. In multivariable analysis, higher peak AAo Doppler (OR, 2.51 [95% CI, 1.54-4.58] per 20 cm/s; P = 0.001) and younger gestational age at diagnosis (OR, 0.81 [95% CI, 0.70-0.93] per week; P = 0.005) were associated with intervention, whereas a higher AAo z-score (OR, 0.65 [95% CI, 0.43-0.94] per z; P = 0.029) and transverse arch dimension (OR, 0.44 [95% CI, 0.18-0.97]; P = 0.05) decreased the risk of intervention.Conclusions
In prenatally suspected coarctation, the variables associated with intervention comprised smaller AAo and transverse arch size, earlier gestational age at diagnosis, and the additional finding of a higher peak AAo Doppler. 相似文献3.
Guillermo F. López-Sánchez Shahina Pardhan Mike Trott Sheila Sánchez-Castillo Sarah E Jackson Mark Tully 《Ophthalmic epidemiology》2020,27(4):272-277
ABSTRACT
Purpose
The aim of the present study was to assess the association between levels of physical activity (PA) and the presence of cataracts in people aged 15–69 years residing in Spain. 相似文献4.
Oluwatobi O Onafowokan Nicola F. Fine Francis Brooks Oliver M. Stokes Timothy WR Briggs Mike Hutton 《European spine journal》2020,29(3):564-578
To examine the strength of evidence available for multiple facet joint injections (FJIs) and medial branch blocks (MBBs), and to report on the variations in the NHS England framework using the getting it right first time (GIRFT) data. Systematic review using patient, intervention, comparison, outcome and study strategy. The literature search using Cochrane, MEDLINE and EMBASE databases using MeSH terms: lumbar spine, spinal injection and facet joint (“Appendix A”). Three studies were identified that investigated the efficacy of multiple FJIs or MBBs. None of these studies reported sustained positive outcomes at long-term follow-up. There is a paucity of levels I and II evidence available for the efficacy of multiple FJIs and MBBs in treating low back pain. GIRFT data show a high degree of variation in the use of multiple FJIs, which would not be supported by the literature. These slides can be retrieved under Electronic Supplementary Material. 相似文献
5.
Effects of optogenetic stimulation of vasopressinergic retinal afferents on suprachiasmatic neurones
Catherine Hume Andrew Allchorne Valery Grinevich Gareth Leng Mike Ludwig 《Journal of neuroendocrinology》2019,31(12)
Physiological circadian rhythms are orchestrated by the hypothalamic suprachiasmatic nucleus (SCN). The activity of SCN cells is synchronised by environmental signals, including light information from retinal ganglion cells (RGCs). We recently described a population of vasopressin‐expressing RGCs (VP‐RGC) that send axonal projections to the SCN. To determine how these VP‐RGCs influence the activity of cells in the SCN, we used optogenetic tools to specifically activate their axon terminals within the SCN. Rats were intravitreally injected with a recombinant adeno‐associated virus to express the channelrhodopsin‐2 and the red fluorescent protein mCherry under the vasopressin promoter (VP‐ChR2mCherry). In vitro recordings in acute brain slices showed that approximately 30% of ventrolateral SCN cells responded to optogenetic stimulation with an increase in firing rate that progressively increased during the first 200 seconds of stimulation and which persisted after the end of stimulation. Finally, application of a vasopressin V1A receptor antagonist dampened the response to optogenetic stimulation. Our data suggest that optogenetic stimulation of VP‐RGC axons within the SCN influences the activity of SCN cells in a vasopressin‐dependent manner. 相似文献
6.
Alastair J. Noyce Sara Bandres‐Ciga Jonggeol Kim Karl Heilbron Demis Kia Gibran Hemani Angli Xue Debbie A. Lawlor George Davey Smith Raquel Duran Ziv Gan‐Or Cornelis Blauwendraat J. Raphael Gibbs David A. Hinds Jian Yang Peter Visscher Jack Cuzick Huw Morris John Hardy Nicholas W. Wood Mike A. Nalls Andrew B. Singleton 《Movement disorders》2019,34(12):1864-1872
7.
8.
9.
10.
Annette E Hay Nicole Mittmann Michael Crump Matthew C Cheung Jessica Sleeth Judy Needham Mike Broekhoven Marina Djurfeldt Lois E Shepherd Ralph M Meyer Bingshu E Chen Joseph L Pater 《Current oncology (Toronto, Ont.)》2021,28(2):1153
In a prospective study, we sought to determine acceptability of linkage of administrative and clinical trial data among Canadian patients and Research Ethics Boards (REBs). The goal is to develop a more harmonized approach to data, with potential to improve clinical trial conduct through enhanced data quality collected at reduced cost and inconvenience for patients. On completion of the original LY.12 randomized clinical trial in lymphoma (), participants were invited to enrol in the Long-term Innovative Follow-up Extension (LIFE) component. Those consenting to do so provided comprehensive identifying information to facilitate linkage with their administrative data. We prospectively designed a global assessment of this innovative approach to clinical trial follow-up including rates of REB approval and patient consent. The pre-specified benchmark for patient acceptability was 80%. Of 16 REBs who reviewed the research protocol, 14 (89%) provided approval; two in Quebec declined due to small patient numbers. Of 140 patients invited to participate, 115 (82%, 95% CI 76 to 88%) from across 9 Canadian provinces provided consent and their full name, date of birth, health insurance number and postal code to facilitate linkage with their administrative data for long-term follow-up. Linkage of clinical trial and administrative data is feasible and acceptable. Further collaborative work including many stakeholders is required to develop an optimized secure approach to research. A more coordinated national approach to health data could facilitate more rapid testing and identification of new effective treatments across multiple jurisdictions and diseases from diabetes to COVID-19. NCT00078949相似文献